Edition:
United Kingdom

LivaNova PLC (LIVN.OQ)

LIVN.OQ on NASDAQ Stock Exchange Global Select Market

120.68USD
6:00pm BST
Change (% chg)

$0.04 (+0.03%)
Prev Close
$120.64
Open
$121.39
Day's High
$121.70
Day's Low
$119.55
Volume
106,038
Avg. Vol
150,076
52-wk High
$131.52
52-wk Low
$68.14

Latest Key Developments (Source: Significant Developments)

Livanova Initiates Believe Aortic Heart Valve Study In The U.S., Canada
Thursday, 11 Jan 2018 

Jan 11 (Reuters) - Livanova Plc ::LIVANOVA INITIATES BELIEVE AORTIC HEART VALVE STUDY IN THE U.S. AND CANADA.LIVANOVA PLC - THE BELIEVE STUDY IS EXPECTED TO ENROLL ABOUT 230 PATIENTS AT 15 SITES FROM U.S. AND CANADA.  Full Article

Livanova To Acquire Imthera Medical
Tuesday, 5 Dec 2017 

Dec 5 (Reuters) - Livanova Plc ::LIVANOVA TO ACQUIRE IMTHERA MEDICAL, INC..LIVANOVA PLC SAYS ENTERED INTO AN AGREEMENT TO ACQUIRE REMAINING OUTSTANDING INTERESTS IN IMTHERA MEDICAL, INC..LIVANOVA PLC SAYS HAS AGREED TO PAY UP TO APPROXIMATELY $225 MILLION TO ACQUIRE REMAINING OUTSTANDING INTERESTS OF IMTHERA.LIVANOVA PLC SAYS DEAL IS PROJECTED TO BE NEAR-TERM ACCRETIVE AND IS EXPECTED TO CLOSE IN EARLY 2018.LIVANOVA PLC SAYS UP-FRONT COSTS FOR THE DEAL ARE APPROXIMATELY $78 MILLION WITH BALANCE PAID ON A SCHEDULE DRIVEN BY REGULATORY AND SALES MILESTONES.  Full Article

LivaNova says breaching co to pay $6 mln if deal with Microport collapses
Monday, 20 Nov 2017 

Nov 20 (Reuters) - Microport Scientific Corp <0853.HK>:LivaNova - If deal to sell co's cardiac rhythm management business to Microport Cardiac Rhythm terminated‍, breaching party to pay termination fee of $6 million.  Full Article

Microport Scientific's unit buys CRM business from Livanova
Monday, 20 Nov 2017 

Nov 20 (Reuters) - Microport Scientific Corp <0853.HK>::Announces ‍acquisition of CRM business from Livanova PLC​.‍Unit buys CRM business for initial consideration of US$190 million​ from Livanova PLC.  Full Article

LivaNova Plc reports ‍Q3 diluted earnings per share were $0.57​
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - LivaNova Plc :LivaNova Plc - ‍Q3 2017 diluted earnings per share were $0.57​.LivaNova Plc - ‍Q3 2017 adjusted diluted earnings per share were $0.93​.LivaNova Plc - ‍Reiterates that worldwide net sales for full-year 2017 will remain between 1 and 3 percent growth on a constant currency basis​.LivaNova Plc - ‍Adjusted diluted earnings per share projections for full-year 2017 are now expected to be in range of $3.30 to $3.45​.LivaNova Plc - Qtrly ‍net sales $309.7 million versus $295.3 million​.Q3 earnings per share view $0.78, revenue view $300.5 million -- Thomson Reuters I/B/E/S.FY2017 earnings per share view $3.25 -- Thomson Reuters I/B/E/S.  Full Article

Livanova receives FDA approval for Vagus Nerve Stimulation Therapy system​
Monday, 9 Oct 2017 

Oct 9 (Reuters) - Livanova Plc ::Livanova receives FDA approvals for SenTiva device and next-generation VNS therapy programming system for treatment of epilepsy.Says received U.S. FDA approvals for Vagus Nerve Stimulation Therapy system​.  Full Article

BRIEF-LivaNova PLC Reports Qtrly Diluted Earnings Per Share From Continuing Operations $0.36

* LIVANOVA PLC - QTRLY WORLDWIDE SALES FROM CONTINUING OPERATIONS $250.4 MILLION, UP 5.3 PERCENT ON CONSTANT CURRENCY BASIS VERSUS Q1 2017

No consensus analysis data available.